Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Additional benefits reported for eplerenone combined with other drugs in hypertension

May 28, 2003

Calblock launched in Japan

May 27, 2003

Ventavis receives positive opinion in Europe

May 27, 2003

Speedel acquires full rights to SPP-301 from Roche

May 26, 2003

Pfizer presents new PDE9 inhibitors with utility in hypertension therapy

May 26, 2003

VIP as a potential treatment for patients with primary pulmonary hypertension

May 26, 2003

Bayer claims new PPARdelta activators in recent patent

May 21, 2003

Electrophysiological effects of drug selectively targeting I(Kur) in myocytes from AF patients

May 20, 2003

Milestone achieved in PROCARDIS consortium study

May 20, 2003

Evotec and Artesian enter CHF drug discovery agreement

May 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...